Bipolar_trader

$AXE Strengthens biochip manufacturing

ASX:AXE   ARCHER MATERIALS LIMITED
Key biosensor components of Archer’s lab-on-a-chip device miniaturised to nanosize chip formats, a requirement for successful biochip development.
• Archer team grows, introducing world-class expertise and capabilities spanning
nanotechnology, advanced materials, and molecular biology.
• The Company is utilising over $150 million of sophisticated chip building facilities
in Australia to manufacture its graphene-based biochip technology.
• Lab-on-a-chip devices form part of the multibillion dollar deep-tech economy,
catalysed by the global need for point of care medical diagnostics and testing†,‡.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.